ResMed (RMD) Reports In-Line Q1 EPS, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $226.74 --0%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.66, in-line with the analyst estimate of $0.66. Revenue for the quarter came in at $523.7 million versus the consensus estimate of $505.61 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
